{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:04:51Z","timestamp":1785297891306,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K08103"],"award-info":[{"award-number":["JP22K08103"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K22274"],"award-info":[{"award-number":["JP24K22274"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008728","name":"Japan Research Foundation for Clinical Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87381-1","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T12:28:35Z","timestamp":1738067315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical characteristics and predictive biomarkers of intensive care unit-acquired weakness in patients with cardiogenic shock requiring mechanical circulatory support"],"prefix":"10.1038","volume":"15","author":[{"given":"Tae","family":"Higuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Nagatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Nezu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouji","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Iyonaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Akahoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Ushijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shiose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Kinugawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtaro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"87381_CR1","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jchf.2020.09.005","volume":"8","author":"BN Tehrani","year":"2020","unstructured":"Tehrani, B. N. et al. A standardized and comprehensive approach to the management of cardiogenic shock. JACC Heart Fail. 8, 879\u2013891 (2020).","journal-title":"JACC Heart Fail."},{"key":"87381_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00392-017-1182-2","volume":"107","author":"M Shah","year":"2018","unstructured":"Shah, M. et al. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin. Res. Cardiol. 107, 287\u2013303 (2018).","journal-title":"Clin. Res. Cardiol."},{"key":"87381_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/ehjacc\/zuac021","volume":"11","author":"KA Krychtiuk","year":"2022","unstructured":"Krychtiuk, K. A., Vrints, C., Wojta, J., Huber, K. & Speidl, W. S. Basic mechanisms in cardiogenic shock: part 1-definition and pathophysiology. Eur. Heart J. Acute Cardiovasc. Care 11, 356\u2013365 (2022).","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"87381_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcrc.2018.08.002","volume":"48","author":"K Hayes","year":"2018","unstructured":"Hayes, K., Holland, A. E., Pellegrino, V. A., Mathur, S. & Hodgson, C. L. Acute skeletal muscle wasting and relation to physical function in patients requiring extracorporeal membrane oxygenation (ECMO). J. Crit. Care 48, 1\u20138 (2018).","journal-title":"J. Crit. Care"},{"key":"87381_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jccase.2015.02.001","volume":"11","author":"N Sasanuma","year":"2015","unstructured":"Sasanuma, N. et al. A five-year follow-up of a patient with fulminant myocarditis who underwent a stepwise and goal-oriented individualized comprehensive cardiac rehabilitation program. J. Cardiol. Cases. 11, 160\u2013163 (2015).","journal-title":"J. Cardiol. Cases"},{"key":"87381_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/00000441-190605000-00020","volume":"131","author":"W Osler","year":"1906","unstructured":"Osler, W. The principles and practice of medicine. Designed for the use of practitioners and students of medicine. Am. J. Med. Sci. 131, 114\u2013118 (1906).","journal-title":"Am. J. Med. Sci."},{"key":"87381_CR7","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1378\/chest.06-2065","volume":"131","author":"WD Schweickert","year":"2007","unstructured":"Schweickert, W. D. & Hall, J. ICU-acquired weakness. Chest 131, 1541\u20131549 (2007).","journal-title":"Chest"},{"key":"87381_CR8","doi-asserted-by":"publisher","first-page":"s299","DOI":"10.1097\/CCM.0b013e3181b6ef67","volume":"37","author":"RD Stevens","year":"2009","unstructured":"Stevens, R. D. et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit. Care Med. 37, s299\u2013308 (2009).","journal-title":"Crit. Care Med."},{"key":"87381_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.chest.2016.03.045","volume":"150","author":"SE Jolley","year":"2016","unstructured":"Jolley, S. E., Bunnell, A. E. & Hough, C. L. ICU-acquired weakness. Chest 150, 1129\u20131140 (2016).","journal-title":"Chest"},{"key":"87381_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00134-020-05944-4","volume":"46","author":"I Vanhorebeek","year":"2020","unstructured":"Vanhorebeek, I., Latronico, N. & Van den Berghe, G. ICU-acquired weakness. Intens. Care Med. 46, 637\u2013653 (2020).","journal-title":"Intensive Care Med."},{"key":"87381_CR11","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1056\/NEJMra1209390","volume":"370","author":"JP Kress","year":"2014","unstructured":"Kress, J. P. & Hall, J. B. ICU-acquired weakness and recovery from critical illness. N. Engl. J. Med. 370, 1626\u20131635 (2014).","journal-title":"N Engl. J. Med."},{"key":"87381_CR12","doi-asserted-by":"crossref","unstructured":"Needham, D. M. et al. Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders\u2019 conference. Crit. Care Med. 40, 502\u2013509 (2012).","DOI":"10.1097\/CCM.0b013e318232da75"},{"key":"87381_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s13539-010-0010-6","volume":"1","author":"JC Schefold","year":"2010","unstructured":"Schefold, J. C., Bierbrauer, J. & Weber-Carstens, S. Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J. Cachexia Sarcopenia Muscle 1, 147\u2013157 (2010).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"87381_CR14","first-page":"e31405","volume":"101","author":"Z Yang","year":"2022","unstructured":"Yang, Z., Wang, X., Wang, F., Peng, Z. & Fan, Y. A systematic review and meta-analysis of risk factors for intensive care unit acquired weakness. Medicine (United States) 101, e31405 (2022).","journal-title":"Medicine (United States)"},{"key":"87381_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/CCM.0b013e31822d7c18","volume":"40","author":"S Derde","year":"2012","unstructured":"Derde, S. et al. Muscle atrophy and preferential loss of myosin in prolonged critically ill patients. Crit. Care Med. 40, 79\u201389 (2012).","journal-title":"Crit. Care Med."},{"key":"87381_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-022-04253-0","volume":"27","author":"B Fazzini","year":"2023","unstructured":"Fazzini, B. et al. The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis. Crit. Care 27, 1\u201326 (2023).","journal-title":"Crit. Care"},{"key":"87381_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1164\/rccm.201512-2344OC","volume":"194","author":"C Dos Santos","year":"2016","unstructured":"Dos Santos, C. et al. Mechanisms of chronic muscle wasting and dysfunction after an intensive care unit stay: a pilot study. Am. J. Respir. Crit. Care Med. 194, 821\u2013830 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"87381_CR18","doi-asserted-by":"publisher","first-page":"792201","DOI":"10.3389\/fmed.2022.792201","volume":"9","author":"X Chen","year":"2022","unstructured":"Chen, X., Lei, X., Xu, X., Zhou, Y. & Huang, M. Intensive care unit-acquired weakness in patients with extracorporeal membrane oxygenation support: frequency and clinical characteristics. Front. Med. (Lausanne) 9, 792201 (2022).","journal-title":"Front. Med. (Lausanne)"},{"key":"87381_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1164\/rccm.200712-1829OC","volume":"178","author":"NA Ali","year":"2008","unstructured":"Ali, N. A. et al. Acquired weakness, handgrip strength, and mortality in critically III patients. Am. J. Respir. Crit. Care Med. 178, 261\u2013268 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"87381_CR20","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1097\/CCM.0b013e3181b027e9","volume":"37","author":"T Sharshar","year":"2009","unstructured":"Sharshar, T. et al. Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit. Care Med. 37, 3047\u20133053 (2009).","journal-title":"Crit. Care Med."},{"key":"87381_CR21","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s001340101009","volume":"27","author":"J Garnacho-Montero","year":"2001","unstructured":"Garnacho-Montero, J. et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intens. Care Med. 27, 1288\u20131296 (2001).","journal-title":"Intensive Care Med."},{"key":"87381_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/cc7100","volume":"12","author":"G Hermans","year":"2008","unstructured":"Hermans, G., De Jonghe, B., Bruyninckx, F. & Van den Berghe, G. Clinical review: critical illness polyneuropathy and myopathy. Crit. Care 12, 238 (2008).","journal-title":"Crit. Care"},{"key":"87381_CR23","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1186\/cc13699","volume":"18","author":"L Wieske","year":"2014","unstructured":"Wieske, L. et al. Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study. Crit. Care 18, R18 (2014).","journal-title":"Crit. Care"},{"key":"87381_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-11440-5","volume":"7","author":"J Morel","year":"2017","unstructured":"Morel, J. et al. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in locomotor and respiratory muscles during experimental sepsis in mice. Sci. Rep. 7, 1\u201312 (2017).","journal-title":"Sci. Rep."},{"key":"87381_CR25","first-page":"559789","volume":"7","author":"AV Kozlov","year":"2020","unstructured":"Kozlov, A. V. et al. Intensive care unit-acquired weakness: a review of recent progress with a look toward the future. Front. Med. (Lausanne) 7, 559789 (2020).","journal-title":"Front. Med. (Lausanne)"},{"key":"87381_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1152\/ajpendo.00039.2012","volume":"303","author":"A Bonetto","year":"2012","unstructured":"Bonetto, A. et al. JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am. J. Physiol. Endocrinol. Metab. 303, 410\u2013421 (2012).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"87381_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40560-024-00734-2","volume":"12","author":"T Oshima","year":"2024","unstructured":"Oshima, T. & Hatakeyama, J. Nutritional therapy for the prevention of post-intensive care syndrome. J. Intens. Care 12, 29 (2024).","journal-title":"J. Intensive Care"},{"key":"87381_CR28","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/CCM.0000000000000040","volume":"42","author":"E Fan","year":"2014","unstructured":"Fan, E. et al. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit. Care Med. 42, 849\u2013859 (2014).","journal-title":"Crit. Care Med."},{"key":"87381_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jcrc.2019.06.022","volume":"53","author":"G Sidiras","year":"2019","unstructured":"Sidiras, G. et al. Long term follow-up of quality of life and functional ability in patients with ICU acquired weakness\u2014A post hoc analysis. J. Crit. Care 53, 223\u2013230 (2019).","journal-title":"J. Crit. Care"},{"key":"87381_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/ijccm.IJCCM_32_17","volume":"21","author":"C Delmas","year":"2017","unstructured":"Delmas, C. et al. Early prediction of 3-month survival of patients in refractory cardiogenic shock and cardiac arrest on extracorporeal life support. Indian J. Crit. Care Med. 21, 138\u2013145 (2017).","journal-title":"Indian J. Crit. Care Med."},{"key":"87381_CR31","doi-asserted-by":"crossref","unstructured":"Patidar, M., Yadav, N. & Dalai, S. K. Interleukin 15: A key cytokine for immunotherapy. Cytokine Growth Factor Rev.  31, 149\u2013159 (2016).","DOI":"10.1016\/j.cytogfr.2016.06.001"},{"key":"87381_CR32","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.1016\/S0828-282X(09)70511-2","volume":"25","author":"B Bigalke","year":"2009","unstructured":"Bigalke, B., Schwimmbeck, P. L., Haas, C. S. & Lindemann, S. Effect of interleukin-15 on the course of myocarditis in Coxsackievirus B3-infected BALB\/c mice. Can. J. Cardiol. 25, e248\u2013e254 (2009).","journal-title":"Can. J. Cardiol."},{"key":"87381_CR33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/FJC.0000000000000061","volume":"63","author":"Y Yeghiazarians","year":"2014","unstructured":"Yeghiazarians, Y. et al. IL-15: a novel pro-survival signaling pathway in cardiomyocytes. J. Cardiovasc. Pharmacol. 63, 406\u2013411 (2014).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"87381_CR34","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1210\/endo.136.8.7628408","volume":"136","author":"LS Quinn","year":"1995","unstructured":"Quinn, L. S., Haugk, K. L. & Grabstein, K. H. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology 136, 3669\u20133672 (1995).","journal-title":"Endocrinology"},{"key":"87381_CR35","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/MAT.0000000000001510","volume":"67","author":"R Lorusso","year":"2021","unstructured":"Lorusso, R. et al. ELSO interim guidelines for venoarterial extracorporeal membrane oxygenation in adult cardiac patients. ASAIO J. 67, 827\u2013844 (2021).","journal-title":"ASAIO J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87381-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87381-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87381-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T12:28:42Z","timestamp":1738067322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87381-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87381"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87381-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"24 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Takeo Fujino is a member of the endowment department supported by NIPRO, Medtronic Japan and Abbott Medical Japan. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"It was conducted in accordance with the Declaration of Helsinki, and we obtained written informed consent after fully explaining the study, risks, and freedom to participate to patients or their families. We obtained the approval of the Ethics Review Committee for Clinical Research of the Kyushu University Medical School District Department (license number: 2019\u2013585, approval date: 2019-2-24, study title: A Study of ICU-AW Occurrence and Improvement of Exercise Capacity in Critical Cardiac Disease).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"3535"}}